OC
TNXP icon

Oppenheimer & Co’s Tonix Pharmaceuticals TNXP Stock Holding History

Oppenheimer & Co’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Hold
0
– -$42K – 1391
2017
Q4 		– Hold
0
– – – 1296
2017
Q3 		– Hold
0
– – – 1264
2017
Q2 		– Hold
0
– – – 1266
2017
Q1 		– Hold
0
– -$34K – 1348
2016
Q4 		– Hold
0
– – – 1255
2016
Q3 		– Hold
0
– – – 1236
2016
Q2 		– Hold
0
– – – 1171
2016
Q1 		– Hold
0
– – – 1194
2015
Q4 		– Hold
0
– – – 1049
2015
Q3 		– Hold
0
– – – 1258

Other funds holding TNXP

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return